The Biotech Growth Trust PLC (BIOG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.52 Million ≈ $-306.25 USD) by net assets (GBX257.88 Million ≈ $31.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of The Biotech Growth Trust PLC for the company's overall valuation and market capitalisation.
The Biotech Growth Trust PLC - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how The Biotech Growth Trust PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
The Biotech Growth Trust PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of The Biotech Growth Trust PLC ranked by their cash flow conversion efficiency. Explore The Biotech Growth Trust PLC (BIOG) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Keyang Electric Machinery Co Ltd
KO:012205
|
-0.186x |
|
CF Energy Corp
V:CFY
|
0.026x |
|
G Capital Public Company Limited
BK:GCAP
|
-0.071x |
|
PBG SA
WAR:PBG
|
0.000x |
|
Forbidden Foods Ltd
AU:FFF
|
-0.112x |
|
Flash Sports & Media Holdings, Inc.
NASDAQ:FLZH
|
-0.002x |
|
Inspire Veterinary Partners, Inc. Class A Common Stock
NASDAQ:IVP
|
-0.308x |
|
ModivCare Inc
NASDAQ:MODV
|
0.937x |
Annual Cash Flow Conversion Efficiency for The Biotech Growth Trust PLC (2012–2025)
The table below shows the annual cash flow conversion efficiency of The Biotech Growth Trust PLC from 2012 to 2025. View The Biotech Growth Trust PLC stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | GBX221.21 Million ≈ $26.91K |
GBX-5.09 Million ≈ $-618.94 |
-0.023x | -95.92% |
| 2024-03-31 | GBX361.31 Million ≈ $43.96K |
GBX-4.24 Million ≈ $-516.01 |
-0.012x | +34.18% |
| 2023-03-31 | GBX330.29 Million ≈ $40.19K |
GBX-5.89 Million ≈ $-716.64 |
-0.018x | +42.10% |
| 2022-03-31 | GBX394.21 Million ≈ $47.96K |
GBX-12.14 Million ≈ $-1.48K |
-0.031x | -226.48% |
| 2021-03-31 | GBX601.47 Million ≈ $73.18K |
GBX-5.67 Million ≈ $-690.36 |
-0.009x | +8.40% |
| 2020-03-31 | GBX365.57 Million ≈ $44.48K |
GBX-3.77 Million ≈ $-458.09 |
-0.010x | +4.27% |
| 2019-03-31 | GBX408.88 Million ≈ $49.75K |
GBX-4.40 Million ≈ $-535.23 |
-0.011x | -9.39% |
| 2018-03-31 | GBX417.40 Million ≈ $50.79K |
GBX-4.11 Million ≈ $-499.46 |
-0.010x | +16.56% |
| 2017-03-31 | GBX448.41 Million ≈ $54.56K |
GBX-5.29 Million ≈ $-643.03 |
-0.012x | +24.47% |
| 2016-03-31 | GBX378.57 Million ≈ $46.06K |
GBX-5.91 Million ≈ $-718.71 |
-0.016x | -1283.70% |
| 2015-03-31 | GBX533.30 Million ≈ $64.89K |
GBX703.00K ≈ $85.53 |
0.001x | +100.86% |
| 2014-03-31 | GBX340.25 Million ≈ $41.40K |
GBX-52.25 Million ≈ $-6.36K |
-0.154x | -3352.62% |
| 2013-03-31 | GBX244.44 Million ≈ $29.74K |
GBX1.15 Million ≈ $140.41 |
0.005x | +267.90% |
| 2012-03-31 | GBX156.13 Million ≈ $19.00K |
GBX-439.00K ≈ $-53.41 |
-0.003x | -- |
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create … Read more